Fig. 1

Correlations of SATB2-AS1, miR-155-3p and BRMS1L expression levels with clinicopathological characteristics and prognosis of BC patients. a Expression of SATB2-AS1 in BC tissues and adjacent normal tissues; b representative images of SATB2-AS1 expression in BC tissues and adjacent normal tissues detected by ISH; c expression of miR-155-3p in BC tissues and adjacent normal tissues; d mRNA expression of BRMS1L in BC tissues and adjacent normal tissues; e protein expression of BRMS1L in BC tissues and adjacent normal tissues; f correlation between SATB2-AS1 and miR-155-3p in BC tissues was analyzed by Pearson test; g correlation between BRMS1L and miR-155-3p in BC tissues was analyzed by Pearson test; h correlation between BRMS1L and SATB2-AS1 in BC tissues was analyzed by Pearson test; i effect of LNM on SATB2-AS1 expression; j effect of TNM stage on SATB2-AS1 expression; k effect of ER status on SATB2-AS1 expression; l effect of PR status on SATB2-AS1 expression; m relation between SATB2-AS1 expression and prognosis of BC patients. The measurement data conforming to the normal distribution were expressed as mean ± standard deviation. The t-test was performed for comparisons between two groups, and one-way ANOVA was used for comparisons among multiple groups and Tukey’s post hoc test was used for pairwise comparisons after one-way ANOVA. The correlations among expression of SATB2-AS1, miR-155-3p and BRMS1L in BC tissues were detected by Pearson’s correlation coefficient test and the Kaplan–Meier analysis was used to analyze the prognosis of BC patients